Beam Therapeutics Inc. (BEAM)
BMV
Closed
Aug 21, 2026
Day's Range
454.0052 wk Range
309.00Overview - BEAM - Beam Therapeutics Inc.
Key Statistics
Valuation
Enterprise Value
751.23B
P/E (Trailing)
‪-560.49‬
PEG Ratio
‪-31.13‬
Price / Sales (TTM)
‪318.69‬
Price / Book
‪2.65‬
EV / EBITDA
‪-124.96‬
Profitability
Profit Margin
‪-55.44%‬
Operating Margin
‪-25,827.14%‬
Return on Assets
‪-17.01%‬
Return on Equity
‪-8.18%‬
Ownership
Shares Outstanding
103.26M
Float
88.24M
Held by Insiders
‪1.37%‬
Held by Institutions
‪107.88%‬
Price stats
Beta
‪2.20‬
50-Day Avg
‪536.96‬
200-Day Avg
‪526.58‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BEAM - Beam Therapeutics Inc.
Peers - BEAM - Beam Therapeutics Inc.
Peer Comparison
Compared with companies in Biotechnology listed on BMV.
- BEAMBMVBeam Therapeutics Inc.46.70BMarket Cap+28.41%52-week change-560.49P/E (Trailing)‪-55.44%‬Profit Margin
- ARGXNBMVargenx SE American Depositary Receipt931.67BMarket Cap+4.58%52-week change33.44P/E (Trailing)‪32.26%‬Profit Margin
- ALNYBMVAlnylam Pharmaceuticals Inc742.50BMarket Cap-54.26%52-week change57.14P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNBMVBioNTech SE492.36BMarket Cap+4.53%52-week change1.65P/E (Trailing)‪-63.63%‬Profit Margin
- BMRNBMVBioMarin Pharmaceutical Inc.218.20BMarket Cap+4.43%52-week change192.34P/E (Trailing)‪2.14%‬Profit Margin
- ACADBMVAcadia Pharmaceuticals Inc.77.69BMarket Cap-12.18%52-week change13.49P/E (Trailing)‪33.41%‬Profit Margin
- AGIOBMVAgios Pharmaceuticals Inc.72.95BMarket Cap+0.00%52-week change5.17P/E (Trailing)‪88.25%‬Profit Margin
Profile Summary - BEAM - Beam Therapeutics Inc.
About
Beam Therapeutics Inc. is a biotechnology company developing precision genetic medicines through its pioneering base editing platform. This technology enables precise single-nucleotide changes in DNA without double-strand breaks, targeting serious genetic diseases. Key programs include BEAM-101, a base editor for…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
